About
Immunotherapies for Cancer
Areas of Focus
Categories
Biologics & BiopharmaceuticalSan Diego & Southern California
Team (11)
Chief Business Officer
Chief Business Officer
Janux Therapeutics
team_member
Chief Medical Officer
Chief Medical Officer
Janux Therapeutics
executive
Chief Scientific Officer
Chief Scientific Officer
Janux Therapeutics
executive
Chief Technical Officer
Chief Technical Officer
Janux Therapeutics
team_member
Founder, President & Chief Executive Officer
Founder, President & Chief Executive Officer
Janux Therapeutics
executivefounder
General Counsel
Janux Therapeutics
team_member
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
402
By Phase
PHASE1: 2
By Status
RECRUITING: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT05783622Lead Sponsor
Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies
PHASE1Recruiting
130 participants
Started: Apr 19, 2023 · Completed: Oct 31, 2027
NCT05519449Lead Sponsor
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
PHASE1Recruiting
272 participants
Started: Sep 15, 2022 · Completed: Dec 31, 2028
Locations (1)
Headquarters
San Diego, CA, United States
Map
Loading map...